The Peptide CommonsEst. May 2024
Independent. We sell nothing and are affiliated with no manufacturer or pharmacy. Every moderation action is logged in public
Topic summary

Pooling trials with different estimands

This is a generated summary. It shows the 9 most-liked posts from a topic of 133, in their original order, with the accepted answer included where one exists. It is a reading aid and it will miss nuance — the full topic is the record.
RC
r.coelhoTL2 Moderator30 May 2026#1

On the subject in the title: Pooling trials with different estimands Working notes rather than a conclusion.

Comparing SELECT (N Engl J Med, 2023) with SURMOUNT-1 (N Engl J Med, 2022) and finding the comparison harder than it looks.

Different populations, different durations, different endpoints defined slightly differently, and in one case a different estimand. People compare the headline percentages anyway, including me until recently.

Is there a defensible way to put these side by side, or is the honest answer that there is not and we should stop?

34 likes 2mo
TS
taper_shiftTL3Regular Solution1 Jun 2026#3

Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still makes sense to read. The error was mine and it was the kind that comes from remembering a figure instead of looking it up.

7 likes 2mo
VT
vial_tableTL2Member8 Jun 2026#13
r.molnar, post #4: Worth separating two things that post #3 runs together. Publication bias: what did not get published? Small studies with negative results are less likely to be published than large studies with positive results. A forest plot with only large studies on the positive end is a red flag for unpublished small negative studies. Go to post

I read post #11 twice before replying, because I had assumed the opposite.

Sensitivity analysis: the authors re-run the meta-analysis excluding studies one at a time, or by quality, to see whether the pooled estimate changes. Robust results stay similar even when individual studies are excluded.

30 likes in reply to #4 2mo
HK
h.kimaniTL2 Moderator22 Jun 2026#41

Picking up post #38: that is the part I would want checked first.

Publication bias: what did not get published? Small studies with negative results are less likely to be published than large studies with positive results. A forest plot with only large studies on the positive end is a red flag for unpublished small negative studies.

32 likes 1mo
IB
i.brobergTL2 Moderator28 Jun 2026#55

Worth separating two things that post #51 runs together.

Inclusion and exclusion criteria: a meta-analysis is only as good as its inclusion criteria. If the criteria are too broad, apples and oranges get pooled. If they are too narrow, the meta-analysis answers a overly specific question.

30 likes 30d
MM
m.malinowskiTL2 Moderator1 Jul 2026#62

Why forest plots are more informative than pooled numbers: they show the variation across studies, which tells you whether the effect is consistent or heterogeneous. A narrow confidence interval around a meaningless centre is less useful than a wider interval that shows real differences.

30 likes 27d
YM
y.mensahTL3Wiki editor4 Jul 2026#69

post #68 is right about the mechanism and I think understates the practical bit.

Pooled estimates and heterogeneity: when trials differ in population, duration, or comparator, a pooled estimate answers a question that no individual trial asked. High heterogeneity means effects genuinely differ across studies. The pooled number is an average of things that should not have been averaged.

29 likes 24d
BN
b.nilsenTL2 Moderator9 Jul 2026#83

Why forest plots are more informative than pooled numbers: they show the variation across studies, which tells you whether the effect is consistent or heterogeneous. A narrow confidence interval around a meaningless centre is less useful than a wider interval that shows real differences.

31 likes 19d
AL
a.lindqvistTL2 Moderator14 Jul 2026#96
m.ramos, post #92: post #91 is right about the mechanism and I think understates the practical bit. I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The distinction being drawn does not survive when you look at the published data for this specific question. I would be glad to be shown wrong on this,… Go to post

post #95 answers the question as asked. The question underneath it is different.

Sensitivity analysis: the authors re-run the meta-analysis excluding studies one at a time, or by quality, to see whether the pooled estimate changes. Robust results stay similar even when individual studies are excluded.

30 likes in reply to #92 14d

Read the full topic (133 posts)

Suggested topics

TopicParticipantsRepliesViewsActivity
Individual participant data versus aggregate data
Posting this under the heading it deserves: Individual participant data versus aggregate data Everything below is what sits behind that. Session topic: SCALE ( N Engl J Med , 2015). Please read it before…
EAKBTEMAK+30 34 64k 14mo
Pooling trials with different estimands — what changed since
Pooling trials with different estimands — what changed since — setting out what I have, and where I think it stops being reliable. Comparing STEP 4 ( JAMA , 2021) with SURPASS-4 ( Lancet , 2021) and finding…
BERRMLDYAW+57 64 12k 7mo
Follow-up: Individual participant data versus aggregate data
Individual participant data versus aggregate data — setting out what I have, and where I think it stops being reliable. Comparing LEADER ( N Engl J Med , 2016) with SURPASS-4 ( Lancet , 2021) and finding the…
HDAPRSGVRV+101 111 23k 18mo
Random versus fixed effects: choosing rather than defaulting
Random versus fixed effects: choosing rather than defaulting — setting out what I have, and where I think it stops being reliable. Session topic: FLOW ( N Engl J Med , 2024). Please read it before posting;…
NPFSMLAJS+16 20 22k 13mo
When a network meta-analysis is defensible and when it is not
When a network meta-analysis is defensible and when it is not I have a specific reason for asking rather than idle curiosity, and the context is below. Comparing SUSTAIN 6 ( N Engl J Med , 2016) with LEADER (…
MVMBC 2 27k 4h

Related topics — sharing the tags publication bias, risk of bias, effect size

TopicParticipantsRepliesViewsActivity
Is there a ceiling dose beyond which semaglutide stops adding benefit?
Is there a ceiling dose beyond which semaglutide stops adding benefit? I have a specific reason for asking rather than idle curiosity, and the context is below. I have seen SURPASS-4 ( Lancet , 2021) cited in…
NHAVBT 2 14k 2mo
Pooling trials with different estimands — what changed since
Pooling trials with different estimands — what changed since — setting out what I have, and where I think it stops being reliable. Comparing STEP 4 ( JAMA , 2021) with SURPASS-4 ( Lancet , 2021) and finding…
BERRMLDYAW+57 64 12k 7mo
Follow-up: What is genuinely unknown about long-term amylin agonism
What is genuinely unknown about long-term amylin agonism I have a specific reason for asking rather than idle curiosity, and the context is below. I have seen SUSTAIN 6 ( N Engl J Med , 2016) cited in support…
NKSADM 2 25k 11mo
Citing a preprint in a maintained document: our rule and its reasoning
On the subject in the title: Citing a preprint in a maintained document: our rule and its reasoning Working notes rather than a conclusion. I have seen SELECT ( N Engl J Med , 2023) cited in support of a…
OVSLTN 2 467 4mo
What TRIUMPH is designed to answer, and why we should not pre-empt it — does this still hold?
Asking directly, because I could not find a straight answer: What TRIUMPH is designed to answer, and why we should not pre-empt it — does this still hold? Session topic: STEP 2 ( Lancet , 2021). Please read…
DNSLITNCAS+43 47 5.5k just now